Prescription drugs and the patient's health.
作者信息
Woods D
出版信息
Can Med Assoc J. 1974 Dec 7;111(11):1269 passim.
Abstract
摘要
相似文献
1
Prescription drugs and the patient's health.处方药与患者健康。
Can Med Assoc J. 1974 Dec 7;111(11):1269 passim.
2
Testing of intraocular drugs for clinical use.临床用眼内药物的检测。
Invest Ophthalmol Vis Sci. 2007 Nov;48(11):4861-3. doi: 10.1167/iovs.07-0532.
3
Clinical research in dentistry and the pharmaceutical industry.
Symp Pharmacol Ther Toxicol Group. 1975 Apr 6:32-7.
4
Current regulatory and scientific considerations for approving biosimilars in Iran.伊朗批准生物类似药的当前监管和科学考量
Biologicals. 2011 Sep;39(5):325-7. doi: 10.1016/j.biologicals.2011.06.019. Epub 2011 Aug 27.
5
Costing drug development.药物研发成本核算
Nat Rev Drug Discov. 2003 Apr;2(4):247. doi: 10.1038/nrd1070.
6
Bioavailability of drugs: principles and problems. Report of a WHO Scientific Group.药物的生物利用度：原理与问题。世界卫生组织科学小组报告
World Health Organ Tech Rep Ser. 1973 Nov;536:1-17.
7
Editorial: Bioavailability, bioequivalence and bias.社论：生物利用度、生物等效性与偏倚
Am J Ophthalmol. 1975 Mar;79(3):518. doi: 10.1016/0002-9394(75)90631-5.
8
Bioavailability, clinical effectiveness, and the public interest.
Pharmacology. 1972;8(1):33-43. doi: 10.1159/000136325.
9
Today's dilemma--will drugs work?当今的困境——药物会起作用吗？
J Am Pharm Assoc. 1971 Jun;11(6):331-3. doi: 10.1016/s0003-0465(16)31670-6.
10
Limitations on the discovery and supply of medicines.药品发现与供应方面的限制。
Proc R Soc Med. 1974 Dec;67(12 Pt 2):1287-92. doi: 10.1177/003591577406712P205.
Zotero 插件